View in EDS

Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2.

Saved in:
Bibliographic Details
Title: Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2.
Authors: Bräutigam, Jacqueline1 (AUTHOR), Bischoff, Iris1 (AUTHOR), Schürmann, Christoph1 (AUTHOR), Buchmann, Giulia1 (AUTHOR), Epah, Jeremy1 (AUTHOR), Fuchs, Simone1 (AUTHOR), Heiss, Elke1 (AUTHOR), Brandes, Ralf P.1 (AUTHOR), Fürst, Robert1 (AUTHOR) fuerst@em.uni-frankfurt.de
Source: Journal of Molecular & Cellular Cardiology. Oct2019, Vol. 135, p97-108. 12p.
Database: Academic Search Ultimate
Description
ISSN:00222828
DOI:10.1016/j.yjmcc.2019.08.001